| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc. | Director | Common Stock | 898 K | $736 K | $0.82 | Feb 28, 2022 | By Spouse |
| Karyopharm Therapeutics Inc. | Director | Common Stock | 714 K | $585 K | $0.82 | Feb 28, 2022 | Direct |
| Verastem, Inc. | Director | Common Stock | 8.88 K | $28.5 K | $3.21 | Jun 18, 2024 | Direct |
| Adicet Bio, Inc. | Director | Common Stock | 5.9 K | $8.44 K | $1.43 | Jun 5, 2024 | Direct |
| Kezar Life Sciences, Inc. | Director | Stock Option (right to buy) | 50 K | Jun 20, 2024 | Direct | ||
| Karyopharm Therapeutics Inc. | Director | Stock Option (right to buy) | 27 K | Feb 28, 2022 | Direct | ||
| Adicet Bio, Inc. | Director | Stock Option (Right to Buy) | 26.4 K | Jun 5, 2024 | Direct | ||
| Verastem, Inc. | Director | Stock Option (right to buy) | 12.5 K | Jun 18, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KZR | Kezar Life Sciences, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
| VSTM | Verastem, Inc. | Jun 18, 2024 | 2 | $0 | 4 | Jun 20, 2024 | Director |
| ACET | Adicet Bio, Inc. | Jun 5, 2024 | 3 | -$8.44 K | 4 | Jun 7, 2024 | Director |
| VSTM | Verastem, Inc. | Mar 11, 2024 | 9 | $0 | 4 | Mar 13, 2024 | Director |
| ACET | Adicet Bio, Inc. | Aug 14, 2023 | 6 | $0 | 4 | Aug 16, 2023 | Director |
| KZR | Kezar Life Sciences, Inc. | Jul 24, 2023 | 8 | $0 | 4 | Jul 26, 2023 | Director |
| KZR | Kezar Life Sciences, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
| ACET | Adicet Bio, Inc. | Jun 1, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director |
| VSTM | Verastem, Inc. | May 15, 2023 | 1 | $0 | 4 | May 16, 2023 | Director |
| VSTM | Verastem, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
| KZR | Kezar Life Sciences, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| ACET | Adicet Bio, Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
| VSTM | Verastem, Inc. | May 12, 2022 | 1 | $0 | 4/A | Dec 20, 2022 | Director |
| KPTI | Karyopharm Therapeutics Inc. | Feb 28, 2022 | 4 | -$127 K | 4 | Mar 2, 2022 | Director |
| KPTI | Karyopharm Therapeutics Inc. | Feb 17, 2022 | 2 | -$220 K | 4 | Feb 22, 2022 | Director |
| KPTI | Karyopharm Therapeutics Inc. | Feb 7, 2022 | 2 | -$133 K | 4 | Feb 9, 2022 | Director |
| KZR | Kezar Life Sciences, Inc. | Jan 3, 2022 | 3 | -$52.7 K | 4 | Jan 5, 2022 | Director |
| ACET | Adicet Bio, Inc. | Nov 17, 2021 | 1 | $0 | 4 | Nov 18, 2021 | Director |
| ACET | Adicet Bio, Inc. | Nov 17, 2021 | 0 | $0 | 3 | Nov 18, 2021 | Director |
| KZR | Kezar Life Sciences, Inc. | Jun 28, 2021 | 1 | $0 | 4 | Jun 30, 2021 | Director |
| VSTM | Verastem, Inc. | Jun 28, 2021 | 1 | $0 | 4 | Jun 30, 2021 | Director |